2 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 2 | Recruiting 2 |
Follow T1DM: new trials by email Literature Review of T1DM trials Research Report on T1DM
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus OPF-310 - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1 / Phase 2 | Recruiting | Otsuka Pharmaceutical Factory, Inc. | 13 | 2025-06-10 | 2026-08-21 |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) CNP-103, Placebo - Type 1 Diabetes Mellitus, T1D | Phase 1 / Phase 2 | Recruiting | COUR Pharmaceutical Development Company, Inc. | 72 | 2025-05-12 | 2026-09-11 |
Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (2) · Autoimmune Diseases (1) · Glucose Metabolism Disorders (1) · Hypoglycemia (1) · Immune System Diseases (1) · Metabolic Diseases (1)
Endocrine System Diseases (2) · Nutritional and Metabolic Diseases (2) · Autoimmune Diseases (1) · Glucose Metabolism Disorders (1) · Immune System Diseases (1) · Metabolic Diseases (1)
Therapeutics (1)
COUR Pharmaceutical Development Company, Inc. (1) · Otsuka Pharmaceutical Factory, Inc. (1)
United States (2)
Paul Peloso, MD (1)